AMAG Pharmaceuticals Inc.

(AMAG) Trade

By |

Profile

AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. Most of the revenues are generated through the sale of Feraheme and Makena which is a hydroxyprogesterone caproate injection.

Contact Information

Website: www.amagpharma.com
Email: llennox@amagpharma.com
Main Phone: +1 617 498-3300
Address: 1100 Winter Street
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02451

Issuer Information

Exchange: NGS
CEO: William K. Heiden
Employees: 467
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. Most of the revenues are generated through the sale of Feraheme and Makena which is a hydroxyprogesterone caproate injection.

Contact Information

Website: www.amagpharma.com
Email: llennox@amagpharma.com
Main Phone: +1 617 498-3300
Address: 1100 Winter Street
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02451

Issuer Information

Exchange: NGS
CEO: William K. Heiden
Employees: 467
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 8.78 $ -0.37 (-4.04%)
Last Price 8.78 Change $ -0.37 Change % -4.04 Tick N/A
Bid 5.00 Bid Size 200.00 Ask 10.12 Ask Size 1,100.00
Open 9.17 High 9.28 Low 8.73 Prev Close 9.15
Last Trade Volume 1.1 mi 52 Wk Hi 26.10 52 Wk Low 8.64
Market Cap 296.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 33,766,939.00 EPS (TTM) -3.87 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 9 31
Number of Buys 8 20
Number of Sells 1 11
Net Activity 33464 201401
Last 10 Buys Shares
John A. Fallon 1,000
William K. Heiden 1,000
Michael A. Narachi 1,000
William K. Heiden 1,000
Michael A. Narachi 1,000
Frank E. Thomas 1,000
Frank E. Thomas 1,000
Frank E. Thomas 1,000
Lee F. Allen 1,000
Lee F. Allen 1,000
Last 10 Sell Shares
William K. Heiden 1,000
Joseph Vittiglio 1,000
Julie Krop 1,000
Julie Krop 1,000
Julie Krop 1,000
William K. Heiden 1,000
William K. Heiden 1,000
Frank E. Thomas 1,000
William K. Heiden 1,000
William K. Heiden 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 26 26 26 26
Low Target Price Estimate 16 16 16 16
Mean Target Price Estimate 21.11 21.11 21.11 21.11
Standard Deviation 3.41 3.41 3.41 3.41
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 1 1
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.78 2.78 2.65 2.65